A comprehensive overview of urogenital, anorectal and oropharyngeal Neisseria gonorrhoeae testing and diagnoses among different STI care providers: a cross-sectional study
Authors:
- Casper D. J. Den HeijerCHCasper D. J. Den Heijer
- Christian J. P. A. HoebeCHChristian J. P. A. Hoebe
- Geneviève A. F. S. van LiereGLGeneviève A. F. S. van Liere
- Jan E. A. M. van BergenJBJan E. A. M. van Bergen
- Jochen W. L. CalsJCJochen W. L. Cals
- Frans S. StalsFSFrans S. Stals
- Nicole H. T. M. Dukers-MuijrersNDNicole H. T. M. Dukers-Muijrers
Open Access
- 20 April 2017
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 17 (1) , 290
Abstract
Gonorrhoea, caused by Neisseria gonorrhoeae (NG), can cause reproductive morbidity, is increasingly becoming resistant to antibiotics and is frequently asymptomatic, which shows the essential role of NG test practice. In this study we wanted to compare NG diagnostic testing procedures between different STI care providers serving a defined geographic Dutch region (280,000 inhabitants). Data on laboratory testing and diagnosis of urogenital and extragenital (i.e. anorectal and oropharyngeal) NG were retrieved from general practitioners (GPs), an STI clinic, and gynaecologists (2006–2010). Per provider, we assessed their contribution regarding the total number of tests performed and type of populations tested, the proportion of NG positives re-tested (3–12 months after treatment) and test-of-cure (TOC, within 3 months post treatment). Overall, 17,702 NG tests (48.7% STI clinic, 38.2% GPs, 13.1% gynaecologists) were performed during 15,458 patient visits. From this total number of tests, 2257 (12.7%) were extragenital, of which 99.4% were performed by the STI clinic. Men were mostly tested at the STI clinic (71%) and women by their GP (43%). NG positivity per visit was 1.6%; GP 1.9% (n = 111), STI clinic 1.7% (n = 131) and gynaecology 0.2% (n = 5). NG positivity was associated with Chlamydia trachomatis positivity (OR: 2.06, 95% confidence interval: 1.46–2.92). Per anatomical location, the proportion of NG positives re-tested were: urogenital 20.3% (n = 36), anorectal 43.6% (n = 17) and oropharyngeal 57.1% (n = 20). NG positivity among re-tests was 16.9%. Proportions of NG positives with TOC by anatomical location were: urogenital 10.2% (n = 18), anorectal 17.9% (n = 7) and oropharyngeal 17.1% (n = 6). To achieve best practice in relation to NG testing, we recommend that: 1) GPs test at extragenital sites, especially men who have sex with men (MSM), 2) all care providers consider re-testing 3 to 12 months after NG diagnosis and 3) TOC is performed following oropharyngeal NG diagnosis in settings which provide services to higher-risk men and women (such as STI clinics).Keywords
This publication has 18 references indexed in Scilit:
- What is needed to guide testing for anorectal and pharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae in women and men? Evidence and opinionBMC Infectious Diseases, 2015
- Who tests whom? A comprehensive overview ofChlamydia trachomatistest practices in a Dutch region among different STI care providers for urogenital, anorectal and oropharyngeal sites in young people: a cross-sectional studySexually Transmitted Infections, 2015
- Sexually transmitted diseases treatment guidelines, 2015.2015
- Diagnosis and treatment of chlamydia and gonorrhoea in general practice in England 2000–2011: a population-based study using data from the UK Clinical Practice Research DatalinkBMJ Open, 2015
- Management rates of sexually transmissible infections by Australian general practitioners, 2000–2012Sexual Health, 2014
- [Summary of the NHG guideline 'The STD consultation'].2014
- The Incidence and Correlates of Symptomatic and Asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae Infections in Selected Populations in Five CountriesSexually Transmitted Diseases, 2011
- Chlamydia control activities in Europe: cross-sectional surveyEuropean Journal of Public Health, 2011
- Trends in sexually transmitted infections in the Netherlands, combining surveillance data from general practices and sexually transmitted infection centersBMC Family Practice, 2010
- Asymptomatic sexually transmitted diseases: the case for screeningPreventive Medicine, 2003